These are the 5 scientists and executives getting the richest off Moderna's spike to record highs (MRNA)

· *Moderna's 30% gain in Monday trading is making a small group of scientists and executives a fortune.*
· *The biotech company surged after announcing phase-one trials of its coronavirus vaccine successfully produced antibodies in all 45 participants.*
· *Moderna now plans to finalize phase-three studies in July before...